This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignee: Cancer Research Technology Limited. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: Pritom Shah: Innovator in Cancer Research
Introduction
Pritom Shah is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of cancer research through his innovative work. With a total of 4 patents, Shah is recognized for his advancements in pharmaceutical compositions aimed at treating proliferative disorders.
Latest Patents
Shah's latest patents focus on autotaxin inhibitory compounds. These compounds are designed to inhibit the activity of the autotaxin (ATX) enzyme. The invention details processes for preparing these compounds and their applications in treating conditions such as cancer and fibrosis, where ATX activity plays a critical role.
Career Highlights
Pritom Shah is currently associated with Cancer Research Technology Limited. His work at this organization emphasizes the development of innovative therapies for cancer treatment. His research has the potential to impact the lives of many patients suffering from proliferative disorders.
Collaborations
Shah collaborates with esteemed colleagues, including Francesca Blum and James Lindsay Carr. These partnerships enhance the research efforts and contribute to the advancement of cancer therapies.
Conclusion
Pritom Shah's contributions to cancer research through his patents and collaborations highlight his commitment to innovation in the medical field. His work continues to pave the way for new treatments that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile